Allogeneic bone marrow derived mesenchymal stem cell therapy (Mayo Clinic)

N/A

Report date: 2023/08/25 20:00:42

Base Information

Drug NameAllogeneic bone marrow derived mesenchymal stem cell therapy (Mayo Clinic)

Drug Alias NameBMD-MSCs

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsLow Back PainConnective Tissue DiseasesLung Diseases, Interstitial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMayo Clinic

China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic

Inactive CompaniesN/A

Active IndicationsLow Back PainConnective Tissue DiseasesLung Diseases, Interstitial

Inactive IndicationsN/A

Other Information

ATC CodeN/A